[1]李 礼,胡娟玉,于正清.IL-19在2型糖尿病患者中的 表达及与血管病变的关系[J].现代检验医学杂志,2016,31(03):92-94.[doi:10.3969/j.issn.1671-7414.2016.03.025]
 LI Li,HU Juan-yu,YU Zheng-qing.Expression of Interleukin-19 and Its Relationship with Angiopathy in 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2016,31(03):92-94.[doi:10.3969/j.issn.1671-7414.2016.03.025]
点击复制

IL-19在2型糖尿病患者中的 表达及与血管病变的关系()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年03期
页码:
92-94
栏目:
论著
出版日期:
2016-06-15

文章信息/Info

Title:
Expression of Interleukin-19 and Its Relationship with Angiopathy in 2 Diabetes Mellitus
文章编号:
1671-7414(2016)03-092-03
作者:
李 礼1胡娟玉2于正清1
1.滨海县人民医院检验科,江苏滨海 224500;
2.滨海县第二人民医院检验科,江苏滨海 224541
Author(s):
LI Li1HU Juan-yu2YU Zheng-qing1
1.Department of Clinical Laboratory, Binhai County People's Hospital,Jiangsu Binhai 224500,China;
2.Department of Clinical Laboratory,Binhai County the Second People's Hospital,Jiangsu Binhai 224541,China
关键词:
白细胞介素-19 2型糖尿病 血管并发症
分类号:
R587.1; R392.11
DOI:
10.3969/j.issn.1671-7414.2016.03.025
文献标志码:
A
摘要:
目的 探讨白细胞介素-19(IL-19)水平在2型糖尿病(T2DM)患者中的表达以及与血管病变的关系。方法 选取T2DM患者120例(其中并发大血管病变32例,微血管病变52例,无血管病变36例),同期选择健康体检者50例为对照组,分别检测研究对象中IL-19,空腹血糖(FBG),胰岛素(FINS)和糖化血红蛋白(HbA1c)水平,并与对照组作比较。结果 T2DM组中IL-19水平显著高于正常对照组(41.9±11.9 pg/ml vs 16.2±8.5 pg/ml),差异有统计学意义(t=7.56,P<0.05)。T2DM并发大血管病变组和微血管病变组IL-19水平显著高于无血管病变组(t=4.57,3.26; 均P<0.05),且与病变血管数量有关。IL-19与胰岛素抵抗(HOMA-IR),HbA1c呈显著正相关(r分别为0.523和0.491,均P<0.01)。结论T2DM患者中IL-19水平显著升高,与HbA1c和HOMA-IR抵抗密切相关,并且IL-19可能参与了T2DM血管病变的发生和发展。
Abstract:
Objective To explore the expression of interleukin-19(IL-19)and to investigate the relationship between IL-19 and type 2 diabetes mellitus9(T2DM)with angiopathy.Methods IL-19,FBG,FINS and HbA1c were measured in 120 T2DM(including 32 patients with macroangiopathy,52 patients with microangiopathy and 36 without angiopathy)and 50healthy subjects,the results were compared.Results Compared with control group,the level of IL-19 in T2DM(41.9±11.9pg/ml vs 16.2±8.5pg/ml)was significantly higher than those of healthy subjects,and thedifference was signifecant(t=7.56,P<0.05).The levels of IL-19 in T2DM with macroangiopathy or microangiopathy increased significantly in comparison withthose without angiopathy(t=4.57,3.26; all P<0.05),and closely correlated with the number of angiopathy.The level of IL-19 in T2DM was significantly positive correlated with HOMA-IR and HbA1c(r=0.523 and 0.491,P<0.01).Conclusion IL-19 level was significantly increased in patients with T2DM,and was closely related with HbA1c,insulin resistance,IL-19 may play acertain role in the pathogenesis of in T2DM with vascularcomplications.

参考文献/References:

[1] Tabata M,Kadomatsu T,Fukuhara S,et al.Angio-poietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance[J].Cell Metab,2009,10(3):178-188.
[2] Richards J,Gabunia K,Kelemen SE,et al.Interleu-kin-19 increases angiogenesis in ischemic hind limbs by direct effects on both endothelial cells andmacrophage polarization[J].J Mol Cell Cardiol,2015(79):21-31.
[3] Sabat R,Wallace E,Endesfelder S,et al.IL-9 and IL-20:two novel cytokines with importance in inflammatory diseases[J].Expert Opin Ther Targets,2007,11(5):601-612.
[4] Barrett JC,Clayton DG,Concannon P,et al.Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes[J].Nat Genet,2009,41(6):703-707.
[5] Chang CS,Magracheva E,Kozlov S,et al.Crystal structure of interleukin-19 defines a new subfamily of helical cytokines[J].J Biol Chem,2003,278(5):3308-3313.
[6] Cuneo AA,Herrick D,Autieri MV,et al.IL-19 reduces VSMC activation byregulation of mRNA regulatory factor HuR and reduction of mRNA stability[J].J Mol Cell Cardiol,2010,49(4):647-654.
[7] Savasan ZA,Chaiworapongsa T,Romero R,et al.Interleukin-19 in fetal systemic inflammation[J].J Matern Fetal Neonatal Med,2012,25(7):995-1005.
[8] Esposito K,Nappo F,Marfella R,et al.Inflammation cytokine concentrations are acutely increased by hyperglycemia in human:role of oxidative stress[J].Circulation,2002,106(16):2067-2070.
[9] Klover PJ,Zimmers TA,Koniaris LG,et al.Chronic exposure to interleukin-6 casues hepatic insulin resistance in mice[J].Diabetes,2003,52(11):2784-2789.
[10] Jain S,Gabunia K,Kelemen SE,et al.The anti-inflammatory cytokine interleukin 19 is expressed by and angiogenic for human endothelial cells[J].Arterioscler Thromb Vasc Biol,2011,31(1):167-175.
[11] 于正清,李 礼,胡娟玉,等.2型糖尿病患者血清CA199与HbA1c的相关性研究[J].现代检验医学杂志,2013,28(3):114-116. Yu ZQ,Li L,Hu JU,et al.Correlation between CA199 and HbA1c in patients with type 2 diabetes millitus[J].Journal of Modern Laboratory Medicine,2013,28(3):114-116.

相似文献/References:

[1]余安运,刘夏炎,宋 煜,等.血清脂蛋白(a)和同型半胱氨酸(HCY) 与2型糖尿病胰岛素抵抗的临床研究[J].现代检验医学杂志,2016,31(03):65.[doi:10.3969/j.issn.1671-7414.2016.03.018]
 YU An-yun,LIU Xia-yan,SONG Yu,et al.Clinical Study of Serum Lipoprotein(a) and Homocysteine with Type 2 Diabetes Mellitus and Insulin Resistance[J].Journal of Modern Laboratory Medicine,2016,31(03):65.[doi:10.3969/j.issn.1671-7414.2016.03.018]
[2]王继贵.基质金属蛋白酶和代谢综合征的研究进展[J].现代检验医学杂志,2015,30(03):1.[doi:10.3969/j.issn.1671-7414.2015.03.001]
 WANG Ji-gui.Progress of Research on Matrix Metalloproteinases and Metabolic Syndrome[J].Journal of Modern Laboratory Medicine,2015,30(03):1.[doi:10.3969/j.issn.1671-7414.2015.03.001]
[3]李国春a,曹 娜a,王 忆b,等.基础血尿酸水平与糖负荷后胰岛素分泌相关性研究[J].现代检验医学杂志,2015,30(02):105.[doi:10.3969/j.issn.1671-7414.2015.02.032]
 LI Guo-chuna,CAO Naa,WANG Yib,et al.Relationship between Concentration of Fasting Uric Acid and Insulin Secretion after Glycemia Burden[J].Journal of Modern Laboratory Medicine,2015,30(03):105.[doi:10.3969/j.issn.1671-7414.2015.02.032]
[4]李晓燕,李晓华,王养维.幽门螺杆菌感染与2型糖尿病发病机制的相关性探讨[J].现代检验医学杂志,2017,32(01):1.[doi:10.3969/j.issn.1671-7414.2017.01.001]
 LI Xiao-yan,LI Xiao-hua,WANG Yang-wei.Helicobacter Pylori Infection and the Pathogeenesis of Type 2Diabetes[J].Journal of Modern Laboratory Medicine,2017,32(03):1.[doi:10.3969/j.issn.1671-7414.2017.01.001]
[5]刘彦君a,梁君蓉b,庞晓宁a.血清趋化素及hs-CRP水平对2型糖尿病患者无症状亚临床动脉粥样硬化诊断的临床意义[J].现代检验医学杂志,2017,32(02):36.[doi:10.3969/j.issn.1671-7414.2017.02.010]
 LIU Yan-juna,LIANG Jun-rongb,PANG Xiao-ninga.Clinical Significance of Serum Chemerin and hs-CRP in the Diagnosis of Subclinical Atherosclerosis in Patients with Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2017,32(03):36.[doi:10.3969/j.issn.1671-7414.2017.02.010]
[6]刘海龙,张维华,吴晓康.肠道菌群在2型糖尿病发病作用中的研究进展[J].现代检验医学杂志,2017,32(04):157.[doi:10.3969/j.issn.1671-7414.2017.04.045]
 LIU Hai-long,ZHANG Wei-hua,WU Xiao-kang.Research Progress on the Function of Intestinal Flora in Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2017,32(03):157.[doi:10.3969/j.issn.1671-7414.2017.04.045]
[7]李 薪,魏力强.2型糖尿病患者血清中脂蛋白相关磷脂酶A2检测的临床意义[J].现代检验医学杂志,2017,32(06):85.[doi:10.3969/j.issn.1671-7414.2017.06.001]
 LI Xin,WEI Li-qiang.Clinical Significance of Detection of Lipoprotein Associated Phospholipase A2 in Serum of Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2017,32(03):85.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[8]张 梅,李林娟,冯旭霞a,等.T2DM并发NAFLD患者血清Nesfatin-1水平变化及相关影响研究[J].现代检验医学杂志,2018,33(01):77.[doi:10.3969/j.issn.1671-7414.2018.01.001]
 ZHANG Mei,LI Lin-juan,FENG Xu-xiaa,et al.Analysis of T2DM to the Serum Nesfatin-1 Level Changes of Patients with NAFLD Horizontal[J].Journal of Modern Laboratory Medicine,2018,33(03):77.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[9]张阳东,周建荣,楚瑞雪,等.PECAM-1基因rs7503550位点多态性和表达水平与冠心病及2型糖尿病的相关性研究[J].现代检验医学杂志,2019,34(03):21.[doi:10.3969/j.issn.1671-7414.2019.03.005]
 ZHANG Yang-dong,ZHOU Jian-rong,CHU Rui-xue,et al.Relativity Study on rs7503550 Polymorphism and Genes Expression Levelsof PECAM-1 in Coronary Artery Disease and Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2019,34(03):21.[doi:10.3969/j.issn.1671-7414.2019.03.005]

备注/Memo

备注/Memo:
基金项目:南京医科大学江苏康达医药卫生发展研究院科研项目(NYKDKJ2015020); 滨海县人民医院科研项目(BYKJ2016)。 作者简介:李 礼(1977-),男,副主任检验师,主要从事临床生化检验诊断,E-mail:lili5898@126.com。
更新日期/Last Update: 2016-06-25